In some cases, nausea, fatigue, headache, and gastric discomfort are reported
Meek CL, Lewis HB, Vergese B, Park A, Reimann F, Gribble F (2016) The effect of encapsulated glutamine on gut peptide secretion in human volunteers
Clinical factors associated with the occurrence of nausea and vomiting in type 2 diabetes patients treated with glucagon-like peptide-1 receptor agonists
GLP-1 Receptor Agonist Market Dynamics The rising prevalence of type 2 diabetes and obesity has resulted in increased demand for GLP-1 receptor agonists
The hybrid OR is a state-of-the-art, innovative, open operating room where patients can receive complex aortic reconstructionsprocedures that have open surgery components to themas well as endovascular (or minimally invasive) aortic reconstructions
[1] CONTRAINDICATIONS History of hypersensitivity reaction to tirzepatide Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) PRECAUTIONS Kidney disease No dose adjustment is recommended in patients with any degree of renal impairment Liver disease No dose adjustment is recommended in patients with any degree of liver disease Stomach disorders Tirzepatide slows gastric emptying and is not recommended in patients with significant stomach disorders, including diabetic gastroparesis General anesthesia or deep sedation GLP-1 therapies, like tirzepatide, slow gastric emptying, possibly increasing the risk of residual gastric contents and pulmonary aspiration in patients receiving anesthesia or deep sedation for procedures
